US President Donald Trump spoke to members of the press at Leh Valley International Airport on Elontown, Pennsylvania, US, August 3, 2025.
Ken Sedeno | Roots
chairman Donald Trump Told CNBC “Squalk box“On Tuesday, the tariff planned on the pharmaceuticals imported into the US can eventually reach 250%, the highest rate is with it. So far threatened,
He said that he would initially impose a “small tariff” on pharmaceuticals, but then “maximum” in a year and a half, he would increase that rate by 150% and then by 250%.
The President has repeatedly threatened and then changed the syllabus on tariff proposals, so there is no guarantee that he will eventually set the drug tariff at 250% rate. In early July, Trump was near 200% tariff threatened On pharmaceuticals.
The Trump administration started a so -called section 232 in April Investigation On drug products. It is a legal right that allows the Commerce Secretary to investigate the impact of import on national security.
Tariffs have been bid for the President to encourage pharmaceutical companies to move manufacturing operations in the US when domestic drug construction has dramatically shrunk over the last few decades. In the last six months, companies like Ellie lily And Johnson & Johnson Fresh US announced Investment To make goodwill with the President.
“We want pharmaceuticals in our country,” Trump told CNBC.
Planned levies will give a blow to the pharmaceutical industry that warns that tariffs can increase costs, prevent investment in the US and disrupt the drug supply chain, which can put patients at risk. Drug manufacturers are already navigating the result from Trump’s drug pricing policies, arguing that their lower lines and their ability to invest in research and development are threatened.
It includes Trump’s Executive Order in May that revives a controversial scheme, the “most preferred nation” policy, aims to reduce the cost of drugs to significantly reduce some drug prices in the US abroad.
On Tuesday, Trump told CNBC that he “invited” the “most preferred nations” policy and “will have a tremendous impact on the cost of the drug.” But Trump has officially not made any changes with the executive order.
Trump last week Letter sent 17 drug manufacturers called him to call by 29 September to reduce American medicine prices. This involves agreeing to provide existing drugs to its full portfolio at the lowest price offered in other developed nations among other stages.
Some pharmaceutical companies have said that they are reviewing the letters.
